Logo image of ALLUX.PA

INSTALLUX SA (ALLUX.PA) Stock Fundamental Analysis

EPA:ALLUX - Euronext Paris - Matif - FR0000060451 - Common Stock - Currency: EUR

302  0 (0%)

Fundamental Rating

6

Taking everything into account, ALLUX scores 6 out of 10 in our fundamental rating. ALLUX was compared to 18 industry peers in the Building Products industry. ALLUX has an excellent financial health rating, but there are some minor concerns on its profitability. ALLUX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALLUX had positive earnings in the past year.
In the past year ALLUX had a positive cash flow from operations.
Each year in the past 5 years ALLUX has been profitable.
Of the past 5 years ALLUX 4 years had a positive operating cash flow.
ALLUX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLUX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

1.2 Ratios

ALLUX's Return On Assets of 5.23% is fine compared to the rest of the industry. ALLUX outperforms 77.78% of its industry peers.
ALLUX has a Return On Equity of 7.70%. This is in the better half of the industry: ALLUX outperforms 61.11% of its industry peers.
ALLUX has a Return On Invested Capital (6.23%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALLUX is in line with the industry average of 6.56%.
The last Return On Invested Capital (6.23%) for ALLUX is above the 3 year average (5.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.23%
ROE 7.7%
ROIC 6.23%
ROA(3y)4.53%
ROA(5y)4.45%
ROE(3y)6.53%
ROE(5y)6.42%
ROIC(3y)5.64%
ROIC(5y)5.67%
ALLUX.PA Yearly ROA, ROE, ROICALLUX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

ALLUX's Profit Margin of 6.14% is amongst the best of the industry. ALLUX outperforms 88.89% of its industry peers.
ALLUX's Profit Margin has declined in the last couple of years.
The Operating Margin of ALLUX (7.91%) is comparable to the rest of the industry.
ALLUX's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 33.41%, ALLUX perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Gross Margin of ALLUX has remained more or less at the same level.
Industry RankSector Rank
OM 7.91%
PM (TTM) 6.14%
GM 33.41%
OM growth 3Y4.06%
OM growth 5Y-8.64%
PM growth 3Y11.07%
PM growth 5Y-7.36%
GM growth 3Y-3.19%
GM growth 5Y-0.41%
ALLUX.PA Yearly Profit, Operating, Gross MarginsALLUX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

9

2. Health

2.1 Basic Checks

ALLUX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ALLUX has about the same amout of shares outstanding than it did 1 year ago.
ALLUX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALLUX is higher compared to a year ago.
ALLUX.PA Yearly Shares OutstandingALLUX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50K 100K 150K 200K 250K
ALLUX.PA Yearly Total Debt VS Total AssetsALLUX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

ALLUX has an Altman-Z score of 3.44. This indicates that ALLUX is financially healthy and has little risk of bankruptcy at the moment.
ALLUX has a Altman-Z score of 3.44. This is amongst the best in the industry. ALLUX outperforms 94.44% of its industry peers.
ALLUX has a debt to FCF ratio of 1.61. This is a very positive value and a sign of high solvency as it would only need 1.61 years to pay back of all of its debts.
ALLUX has a Debt to FCF ratio of 1.61. This is amongst the best in the industry. ALLUX outperforms 100.00% of its industry peers.
ALLUX has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
ALLUX's Debt to Equity ratio of 0.15 is amongst the best of the industry. ALLUX outperforms 94.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.61
Altman-Z 3.44
ROIC/WACC0.91
WACC6.88%
ALLUX.PA Yearly LT Debt VS Equity VS FCFALLUX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

ALLUX has a Current Ratio of 3.26. This indicates that ALLUX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALLUX (3.26) is better than 94.44% of its industry peers.
A Quick Ratio of 2.58 indicates that ALLUX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.58, ALLUX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.26
Quick Ratio 2.58
ALLUX.PA Yearly Current Assets VS Current LiabilitesALLUX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 138.08% over the past year.
Measured over the past years, ALLUX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.92% on average per year.
The Revenue has decreased by -1.59% in the past year.
ALLUX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.36% yearly.
EPS 1Y (TTM)138.08%
EPS 3Y24.73%
EPS 5Y-2.92%
EPS Q2Q%74.68%
Revenue 1Y (TTM)-1.59%
Revenue growth 3Y9.74%
Revenue growth 5Y3.36%
Sales Q2Q%-1.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALLUX.PA Yearly Revenue VS EstimatesALLUX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
ALLUX.PA Yearly EPS VS EstimatesALLUX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.28, the valuation of ALLUX can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ALLUX indicates a rather cheap valuation: ALLUX is cheaper than 88.89% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. ALLUX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.28
Fwd PE N/A
ALLUX.PA Price Earnings VS Forward Price EarningsALLUX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

94.44% of the companies in the same industry are more expensive than ALLUX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALLUX is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.29
EV/EBITDA 2.93
ALLUX.PA Per share dataALLUX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

ALLUX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

ALLUX has a Yearly Dividend Yield of 2.65%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.24, ALLUX pays a better dividend. On top of this ALLUX pays more dividend than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, ALLUX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.65%

5.2 History

The dividend of ALLUX decreases each year by -0.24%.
Dividend Growth(5Y)-0.24%
Div Incr Years0
Div Non Decr Years3
ALLUX.PA Yearly Dividends per shareALLUX.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2 4 6

5.3 Sustainability

ALLUX pays out 24.57% of its income as dividend. This is a sustainable payout ratio.
The Dividend Rate of ALLUX has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP24.57%
EPS Next 2YN/A
EPS Next 3YN/A
ALLUX.PA Yearly Income VS Free CF VS DividendALLUX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M
ALLUX.PA Dividend Payout.ALLUX.PA Dividend Payout, showing the Payout Ratio.ALLUX.PA Dividend Payout.PayoutRetained Earnings

More info and screens

INSTALLUX SA

EPA:ALLUX (3/7/2025, 7:00:00 PM)

302

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)03-27 2025-03-27
Inst Owners9.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap84.56M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.65%
Yearly Dividend8
Dividend Growth(5Y)-0.24%
DP24.57%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.28
Fwd PE N/A
P/S 0.57
P/FCF 4.29
P/OCF 3.55
P/B 0.72
P/tB 0.73
EV/EBITDA 2.93
EPS(TTM)32.54
EY10.77%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)70.33
FCFY23.29%
OCF(TTM)85.18
OCFY28.2%
SpS529.22
BVpS421.83
TBVpS413.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.23%
ROE 7.7%
ROCE 8.48%
ROIC 6.23%
ROICexc 10.8%
ROICexgc 11.14%
OM 7.91%
PM (TTM) 6.14%
GM 33.41%
FCFM 13.29%
ROA(3y)4.53%
ROA(5y)4.45%
ROE(3y)6.53%
ROE(5y)6.42%
ROIC(3y)5.64%
ROIC(5y)5.67%
ROICexc(3y)8.82%
ROICexc(5y)8.33%
ROICexgc(3y)9.05%
ROICexgc(5y)8.51%
ROCE(3y)7.67%
ROCE(5y)7.71%
ROICexcg growth 3Y13.87%
ROICexcg growth 5Y-13.96%
ROICexc growth 3Y13.44%
ROICexc growth 5Y-14.04%
OM growth 3Y4.06%
OM growth 5Y-8.64%
PM growth 3Y11.07%
PM growth 5Y-7.36%
GM growth 3Y-3.19%
GM growth 5Y-0.41%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.61
Debt/EBITDA 0.91
Cap/Depr 51.86%
Cap/Sales 2.81%
Interest Coverage 250
Cash Conversion 120.78%
Profit Quality 216.43%
Current Ratio 3.26
Quick Ratio 2.58
Altman-Z 3.44
F-Score7
WACC6.88%
ROIC/WACC0.91
Cap/Depr(3y)53.36%
Cap/Depr(5y)69.58%
Cap/Sales(3y)2.85%
Cap/Sales(5y)3.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)138.08%
EPS 3Y24.73%
EPS 5Y-2.92%
EPS Q2Q%74.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.59%
Revenue growth 3Y9.74%
Revenue growth 5Y3.36%
Sales Q2Q%-1.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y142.67%
EBIT growth 3Y14.19%
EBIT growth 5Y-5.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y868.28%
FCF growth 3Y46.45%
FCF growth 5Y38.62%
OCF growth 1Y866.37%
OCF growth 3Y32.92%
OCF growth 5Y13.88%